Stock Markets May 4, 2026 06:30 AM

GMR Solutions files for U.S. IPO seeking up to $797.9 million

Global Medical Response-parent GMR Solutions proposes 31,914,893-share offering on NYSE under ticker GMRS with $22-$25 price range

By Hana Yamamoto
GMR Solutions files for U.S. IPO seeking up to $797.9 million

GMR Solutions Inc., the private equity-backed operator of Global Medical Response, submitted a registration for an initial public offering on Monday that seeks to raise as much as $797.9 million. The proposed deal would list the company on the New York Stock Exchange under the symbol GMRS, offering 31,914,893 shares in a price range of $22 to $25 per share. The offering names a large syndicate of lead and co-managing underwriters, including J.P. Morgan, KKR and several major investment banks.

Key Points

  • GMR Solutions filed for a U.S. initial public offering targeting up to $797.9 million.
  • The company plans to offer 31,914,893 shares at a proposed price range of $22 to $25 per share and to list on the NYSE under ticker GMRS.
  • A multi-bank syndicate led by J.P. Morgan, KKR and several major investment banks is named as underwriters; the company operates under the Global Medical Response brand and is backed by KKR, affecting the emergency medical services and financial markets sectors.

GMR Solutions Inc. filed on Monday for an initial public offering that targets proceeds of up to $797.9 million. The company intends to list on the New York Stock Exchange under the ticker GMRS.

The proposed offering comprises 31,914,893 shares, with an indicated price band of $22 to $25 per share. The figure of up to $797.9 million represents the maximum amount the company aims to raise through the sale at that stated range.

GMR Solutions operates under the primary brand Global Medical Response and is described in the filing as the largest provider of emergency medical services and integrated out-of-hospital care in the United States. The company is backed by private equity firm KKR, as noted in the registration.

The syndicate leading the offering includes J.P. Morgan, KKR, BofA Securities, Barclays, Goldman Sachs & Co. LLC, Citigroup, Evercore ISI, Morgan Stanley, and UBS Investment Bank. Additional underwriters listed in the filing are Capital One Securities, Loop Capital Markets, Regions Securities LLC, and Strong Capital Markets.

The filing provides the basic terms of the proposed public offering, including share count, the proposed price range per share, the listing venue and the roster of underwriters. Beyond those items, the document presents the company's self-description as an operator of emergency medical and out-of-hospital care services and identifies its private equity ownership.

No further operational metrics, financial details or timelines for the offering were included in the information referenced here. The filing sets out the structure and participants for the potential public sale of stock but does not itself finalize the share price or the ultimate proceeds.


Contextual summary

The registration establishes the size of the proposed equity sale, the intended NYSE listing symbol GMRS, the number of shares to be offered and the proposed pricing range. It also identifies the lead and supporting underwriters and confirms KKR as the private equity backer and Global Medical Response as the primary operating brand.

Risks

  • The stated $22 to $25 per-share range indicates the final offering price is not yet determined, so proceeds up to $797.9 million are a target rather than a guarantee - this uncertainty affects prospective investors and capital markets.
  • The filing outlines the planned structure and participants but does not specify final financial terms or timing, leaving the ultimate outcome of the offering dependent on future decisions and market conditions.
  • While the company is described as the largest provider of emergency medical services and out-of-hospital care in the U.S., the registration does not provide additional operational or financial details in this notice, limiting the available information for investors assessing the healthcare and financial sectors.

More from Stock Markets

Barclays: Large-cap consumer goods firms absorb higher input costs and keep profit guidance May 4, 2026 Morgan Stanley Adds DBS to Asia ex-Japan Focus List, Drops UOB May 4, 2026 EagleRock Land files for $346 million US IPO, positions acreage for oil and wider energy uses May 4, 2026 U.S. Officials and Alphabet CEO Meet to Tackle AI Processing Shortfall May 4, 2026 Assertio Share Price Jumps After Garda Raises Cash Tender Offer to $21.80 May 4, 2026